12 Panel Drug Test Cup: Analytes, Cutoffs and Spec Sheet

Short answer: a 12 panel drug test cup is a urine collection cup with built-in test strips that screen for twelve drug classes at once, and the number 12 does not fix which twelve. Two real 12-panel documents, an FDA 510(k) summary and a manufacturer package insert, list different drug sets: one includes tricyclic antidepressants (TCA), the other buprenorphine (BUP). The specification that decides whether a cup fits a use is on its paperwork: the intended-use statement, the cutoff for each drug, and the confirmation statement.

Who uses it: the two documents differ. The insert for the Rapid Response cup says it is for professional in vitro diagnostic use only. The FDA summary for the First Check cup says it is intended for over-the-counter consumer use and is not intended for workplace testing. Clinic staff, buyers and students reading a product label should start there.

What a 12 panel drug test cup is

It is a qualitative, presumptive screening device. In the FDA decision summary for the First Check Multi Drug Cup 12 (K052115), the assay is a lateral flow immunochromatographic test that gives a preliminary result only; the summary states that a more specific alternate chemical method must be used to obtain a confirmed result. Related CASRAI pages cover the parts of a cup in urine drug screen cups, the panel-count difference in 5-panel vs 10-panel drug tests, the oral alternative in saliva drug tests, and what CLIA-waived test means.

How it works

The Rapid Response insert describes a competitive-binding immunoassay: a control line must appear for the test to be valid, and no colored line in a drug’s test region means that drug is at or above its cutoff concentration. A positive therefore means the drug or a metabolite is present at or above the cutoff; the insert states it does not indicate intoxication. The insert also notes that adulterants such as bleach or alum can cause erroneous results.

What the numbers and abbreviations on the label mean

Each abbreviation names a drug class. Each has a calibrator (the compound the strip is set against) and a cutoff in ng/mL, the concentration at or above which the strip reads positive. The table sets two real 12-panel documents beside the federal initial-test cutoffs in 49 CFR 40.85 (Cornell LII).

Label	Calibrator (Rapid Response insert)	First Check 510(k) cutoff	Rapid Response cutoff	49 CFR 40.85 initial cutoff
THC	11-nor-delta9-THC-9-carboxylic acid	50	50	50 (marijuana metabolites)
COC	Benzoylecgonine	300	300	150
AMP	d-Amphetamine	1,000	1,000	500 (amphetamine/methamphetamine)
MET	d-Methamphetamine	1,000	1,000	500 (amphetamine/methamphetamine)
MDMA	MDMA	500	500	500 (MDMA/MDA)
OPI	Morphine	2,000	2,000	2,000 (codeine/morphine)
PCP	Phencyclidine	25	25	25
OXY	Oxycodone	100	100	100 (oxycodone/oxymorphone)
BZO	Oxazepam	300	300	not in the table
BAR	Secobarbital	300	300	not in the table
MTD	Methadone	300	300	not in the table
TCA	n/a (not on this panel)	1,000	not on this panel	not in the table
BUP	Buprenorphine	not on this panel	10	not in the table

Two readings follow from the table. First, the twelfth drug differs (TCA versus BUP). Second, the cutoff belongs to the device, not to the panel count: both cups use 300 ng/mL for cocaine and 1,000 ng/mL for amphetamine and methamphetamine, while the federal initial cutoffs are 150 and 500. The First Check summary adds that for BAR, BZO, TCA and OXY there are no uniformly recognized drug levels in urine, and that the SAMHSA-recommended cutoffs it followed covered methamphetamine, THC, cocaine metabolites, amphetamines, opiates and PCP.

Which specification matters most

For a facility ordering cups, the documents point to three, in this order:

1. Intended use. Professional in vitro diagnostic use versus over-the-counter consumer use, and the explicit statement “not intended for workplace testing” where present.
2. Drug list and cutoffs. Which twelve analytes, and the ng/mL cutoff for each, as in the table above.
3. Confirmation statement. Both documents state that a positive is preliminary and must be confirmed by another method; the insert says a positive result must be confirmed by another test method at a toxicology laboratory.

How to read a manufacturer spec sheet

• Analyte list and calibrators: match each label abbreviation to a named compound, as in the second column above.
• Cutoff column: check units (ng/mL) and compare against any cutoff your own use requires.
• Intended-use line: the first sentence of the insert or 510(k) summary; it sets who may use the device.
• Regulation and product-code lines in a 510(k) summary: K052115 lists several single-analyte regulation sections and product codes, because a multi-analyte cup is cleared across several single-analyte categories.
• Controls: the Rapid Response insert states external controls are not supplied with the kit.

What compatibility questions should I ask before ordering?

Ask the manufacturer or distributor for these documents:

• The current package insert, including the analyte and cutoff table.
• The FDA 510(k) number or other FDA record for the cup. CLIA-waived status is a per-product record in FDA’s CLIA database, so it should be checked for the exact product, not assumed from the panel count.
• The stated intended-use setting and whether workplace testing is excluded.
• The confirmation method and laboratory route the insert describes.

Handling basics

Each cup is used under its own package insert, which governs collection, reading and disposal for that product; this page does not replace it. The Rapid Response insert states that external controls are not supplied with the kit and that adulterants such as bleach or alum can cause erroneous results.

Common mistakes

• Assuming every 12-panel cup tests the same twelve drugs.
• Assuming a cup’s cutoffs match the federal initial-test cutoffs.
• Treating a positive as confirmed, or as a sign of intoxication, when the documents say it is presumptive.

FAQ

What do the numbers and abbreviations on the label mean?

The letters name a drug class (for example COC for cocaine metabolite); the number beside each is the cutoff in ng/mL at or above which that strip reads positive.

Which specification matters most when ordering for a facility?

Intended use first, then the cutoffs per drug, then the confirmation statement. Both documents call a positive result preliminary.

How do I read a manufacturer spec sheet?

Match each abbreviation to its calibrator and cutoff, read the intended-use line, then the confirmation and procedure statements. See the decoder list above.

What compatibility questions should I ask before ordering?

Ask for the package insert, the FDA record for the product, the intended-use setting, and the confirmation method.

Sources

• FDA 510(k) decision summary K052115, First Check Diagnostics, Multi Drug Cup 12: https://www.accessdata.fda.gov/cdrh_docs/reviews/K052115.pdf (checked 2026-11-01).
• Rapid Response One Step 12 Panel DOA Cup (Urine) package insert (distributor-hosted copy of the manufacturer instructions): https://cdn.shopify.com/s/files/1/0383/1229/files/Rapid_Response_One_Step_12_Panel_DOA_Cup.pdf (checked 2026-11-01).
• 49 CFR 40.85, initial test cutoff concentrations for urine: https://www.law.cornell.edu/cfr/text/49/40.85 (checked 2026-11-01).